Bringing the Oncology Community Together
Login
|
Register
Home
Nurses
Urology
Targeted Therapies
Interactive
Meetings
OncLive TV
Blogs
Hennessy's Highlights
Publications
Bone Mets
Breast
GI Cancer
GU Cancer
Head & Neck
Hem-Onc
Lung
Skin
Prostate
Patients
Supportive Care
Women's Cancer
Filter by Specialty
Bone Metastases
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Head and Neck Cancer
Hematologic
Lung Cancer
Skin Cancers
Prostate Cancer
Women's Cancer
For Nurses
Pathways, Science, and Research
For Patients
Supportive Care
Targeted Therapies Videos
Dr. Spector on the Importance of Tumor Microenvironments
Dr. Perez on the Mayo Clinic Breast Cancer Genomic Study
Dr. Spector Discusses the Systemic Nature of Cancer
Dr. Perou on Next Generation Sequencing Technology
Dr. Zelenetz Discusses DLBCL Targeted Therapies
Dr. Ellis Describes Breast Cancer Heterogeneity
Dr. Spector Discusses the Complexities of Cancer
Dr. Dunleavy Discusses ABC DLBCL Research
Dr. Perez-Soler on the Future of Lung Cancer Therapies
Dr. Ramaswamy Discusses Tumor Heterogeneity
Dr. Belani Discusses Driver Mutations in NSCLC
Dr. Burris on Pathological CR as a Trial Endpoint
Dr. Leyland-Jones Discusses Genome Sequencing
Dr. Bloom Explains Situations Requiring HER2 Retesting
Dr. Ramaswamy on Dormant Tumor Cells and Resistance
Dr. Burris Discusses the Stratification of Clinical Trials
Dr. Baselga on the Basis Behind the BOLERO-2 Trial
Dr. Cohen on mTOR Inhibition in Head and Neck Cancer
Dr. Ramaswamy on Targeting Dormant Cancer Cells
Dr. Burris Discusses Targeting the mTOR Pathway
Dr. Cohen Addresses the Role of the Hedgehog Pathway
Dr. Bloom Compares HER2 Screening Assays
Dr. Berenson Discusses Early Phase Proteasome Inhibitors
Dr. Burstein on Pathological Complete Response
Dr. Cohen Discusses Hedgehog Pathway Inhibition
Dr. Chan Discusses the VEGF-Trap Agent Aflibercept
John Theurer Cancer Center Partnership Tour
Dr. Baselga Describes the Advantages of Dual Blockade
Dr. Mehra Discusses DNA Repair Enzymes
Dr. Markman Discusses Diagnostic Molecular Testing
Dr. Cohen Discusses Head and Neck Cancer Pathways
Dr. Grimm on the Brain Cancer Predictive Marker MGMT
Dr. Goy Explains the Concept of Personalized Medicine
Dr. Goldstein on Fulvestrant in Metastatic Breast Cancer
Dr. Mills Discusses the Field of Targeted Therapeutics
Dr. Goy Highlights Recent Advances in Oncology
Dr. Iruela-Arispe on the Dr. Paul Janssen Award Symposium
Dr. Scagliotti on the Future of Multiple Gene Profiles
Dr. Scagliotti on Mechanisms of Resistance to EGFR TKIs
Dr. Mills on the Development of Combination Therapies
Dr. Langer Discusses the JMEN Maintenance Pemetrexed Trial
Dr. McDonald on the Continued Understanding of Bevacizumab
Dr. Rugo on Proliferation as an Anti-Angiogenesis Marker
Dr. Langer on Assessing Patient Populations in Trials
Dr. Mills Explains the Vulnerability of Cancer Cells
Dr. Morrow Describes the ACOSOG Z11 Trial
Dr. Wakelee on Adjuvant Therapy Predictive Markers
Dr. Mills on the Shifts Towards Personalized Medicine
Dr. Dixon on Systems Biology for Combination Therapy
Dr. Scagliotti on the Benefits of EGFR Targeted Therapy
Dr. Ellis on Genome Forward Breast Cancer Treatment
Dr. Tripathy Discusses Breast Carcinoma Heterogeneity
Dr. Li Describes the Future of Lung Cancer Therapy
Dr. Rugo on VEGF-A as an Avastin Response Predictor
Dr. Scagliotti Discusses EGFR Mutations in NSCLC
Dr. Dixon on Letrozole With Pathway Inhibitors
Dr. O'Shaughnessy on the Future of TNBC Treatment
Dr. Ellis on Hopeful ER+/HER2- Breast Cancer Paradigms
Dr. Scagliotti on Tailored Treatment & Host Genomics
Dr. McDonald on the Next Step for Angiogenesis Inhibitors
Dr. Tripathy Discusses Biomarker Use in Clinical Trials
Dr. Li Discusses the EML4-ALK Fusion Gene
Dr. O'Shaughnessy on the Future of Breast Cancer
Dr. McDonald on Resistance to Angiogenesis Inhibitors
Dr. Scagliotti Discusses the Future of Lung Cancer Therapy
Dr. Rugo on Anti-Angiogenesis Therapy Response Predictors
Dr. Ellis on Measuring Endocrine Therapy Efficacy
Dr. Tripathy on Connecting Markers to Clinical Outcomes
Dr. Ellis on Ki67 as Treatment Monitoring Biomarkers
Dr. O'Shaughnessy on Breast Cancer Biomarkers
Dr. Ellis Discusses the Future of the PI3-Kinase Pathway
Dr. Ellis Discusses the Cell-Proliferation Marker Ki67
Dr. Reckamp on Current Heat Shock Protein Clinical Trials
Dr. Tripathy Discusses HER2 Targeted Therapies
Dr. Tripathy on Completing New Assays After Recurrence
Dr. Wolff Discusses the Importance of HER2 Testing
Dr. Tripathy on the Oncotype DX Assay Recurrence Score
Dr. Tripathy Discusses Breast Cancer Biomarkers
Dr. Kris Discusses Available Targeted Therapies
Dr. West Discusses Anticipated Future Clinical Trials
Dr. Kris on How the Institutes in His Study Worked Together
Dr. West on 4 Important Upcoming Clinical Trial Results
Dr. Tsimberidou on the Next Steps for Personalized Care
Dr. Hoos on Why Melanoma is Amenable to Immunotherapy
Dr. Kris Explains the Use of Gene Signatures
Dr. Tsimberidou on the Personalized Medicine Results
Karen Hagemaster on Chemo Documentation Study
Dr. Hoos Explains the Future of Immunotherapy
Dr. Hoos Describes Ipilimumab and Future Immunotherapies
Dr. Turnham on the Melanoma Research Foundation
Dr. Hoos on Tools Available to Measure Ipilimumab's Success
Dr. Schuchter on the Next Steps in Melanoma Research
Dr. Kris Talks About Defining Biomarkers
Dr. Hoos Discusses the Clinical Kinetics of Immunotherapy
Dr. Rini on the Results From His Axitinib and Sorafenib Trial
Dr. Infante on the Next Step in Melanoma Research
Dr. Vogelzang Discusses Cabozantinib Trial Design
Donna Berry on the Future of Oncology Nursing
Donna Berry on the Implications of Oral Oncolytics
Dr. Pecora on the Pathway Inhibitor Cabozantinib
Jane Armer on Findings From Her Lymphedema Research
Dr. Edith Perez Discusses Her Ongoing Research
Dr. Gomella on Jefferson's Multidisciplinary Cancer Center
Dr. Alter on Trials and Ongoing Research in Kidney Cancer
Dr. Pearlstone on Ongoing Research in Breast Cancer
Dr. Pecora on his Personal Involvement in Research
What Separates MSKCC From Cancer Centers Worldwide
Oncology Specialists
A
Robert S. Alter, MD
Claudio Anasetti, MD
Stephen Ansell, MD, PhD
Jane M. Armer, RN, PhD
B
Paul Baas, MD, PhD
Wayne A. Bardwell, PhD, MBA
José Baselga, MD, PhD
Suzanne Beauchene, BSN, RN
Chandra P. Belani, MD
James R. Berenson, MD
Donna Berry, PhD, RN
Michael J. Birrer, MD, PhD
Elizabeth Blasiak, RN, MSN
Kenneth J. Bloom, MD
Patrick Borgen, MD
Jeffrey D. Bradley, MD
Carlton Brown, RN, PhD
Adam Brufsky, MD, PhD
Howard A. Burris, III, MD
Barbara Burtness, MD
Harold J. Burstein, MD, PhD
C
Lisa A. Carey, MD
David Cella, PhD
John Chabot, MD
Emily Chan, MD, PhD
Jenny C. Chang, MD
Paul Chapman, MD
Patrick W. Cobb, MD
Deirdre J. Cohen, MD
Ezra Cohen, MD
Daniel R. Couriel, MD
E. David Crawford, MD
D
Nancy E. Davidson, MD
Volker Diehl, MD
J. Michael Dixon, MBChB, MD
Robert Dreicer, MD
Kieron Dunleavy, MD
Beth DuPree, MD
E
Matthew J. Ellis, MD, PhD
Harry Erba, MD, PhD
F
Tatyana Feldman, MD
Kenneth E. Fleisher, DDS
Kevin R. Fox, MD
Harold P. Freeman, MD
G
Reynaldo Garcia, RN, OCN
Lori J. Goldstein, MD
Leonard G. Gomella, MD
Elizabeth M. Gore, MD
Andre Goy, MD, MS
Gregory A. Grabowski, MD
Julie R. Gralow, MD
Sean Grimm, MD
Axel Grothey, MD
H
Karen Hagemaster, RN, BSN
Paul A. Hamlin, MD
Janet Hampton, RN, BS
Harold A. Harvey, MD
Mary J. C. Hendrix, PhD
Roy S. Herbst, MD, PhD
Axel Hoos, MD, PhD
Gabriel N. Hortobagyi, MD
Kristie Howlett, MS, RN
Clifford A. Hudis, MD
Charles Hugh-Jones, MD
I
Jeffrey Infante, MD
Luisa Iruela-Arispe, PhD
J
Elias Jabbour, MD
Sundar Jagannath, MD
Maxine S. Jochelson, MD
Heikki Joensuu, MD, PhD
K
Beth Y. Karlan MD
Shayma Kazmi, MD
Kemp Kernstine, MD, PhD
James N. Kochenderfer, MD
Mark G. Kris, MD
L
Corey J. Langer, MD
Peter Langmuir, MD
Brian Leyland-Jones, MD, PhD
Tianhong Li, MD, PhD
Allen S. Lichter, MD
Christopher J. Logothetis, MD
M
Juanita Madison, MN, RN
Eleftherios P. Mamounas, MD
Maurie Markman, MD
Anthony R. Mato, MD
Fiona McCaughan, RN, MS
Donald M. McDonald, MD, PhD
Ranee Mehra, MD
Ruben A. Mesa, MD
Laura Metcalfe, MSN, RN
Gordon B. Mills, MD, PhD
Pramod K. Mistry, MD, PhD
Supriya G. Mohile, MD, MS
Ana M. Molina, MD
Dana Monroe, RN, BSN
Susan Moore, RN, MSN
Joanna L. Morales, Esq
Monica Morrow, MD
Richard Moscicki, MD
Jamie Myers, PhD, RN
O
Ted Okon
Colleen O'Leary, MSN
Susan M. O'Brien, MD
Joyce A. O'Shaughnessy, MD
Daniel A. Osman, MD
P
Luis Paz-Ares, MD, PhD
David Pearlstone, MD
Andrew L. Pecora, MD
Edith A. Perez, MD
Roman Perez-Soler, MD
Charles M. Perou, PhD
Daniel P. Petrylak, MD
Marshall Posner, MD
Sandhya Pruthi, MD
R
Sridhar Ramaswamy, MD
Karen Reckamp, MD, MS
Brian I. Rini, MD
Michael Rotkowitz, MD
Hope S. Rugo, MD
S
Angel Sanchez, MD
Howard M. Sandler, MD
Oliver Sartor, MD
Giorgio V. Scagliotti, MD, PhD
Howard I. Scher, MD
Freya R. Schnabel, MD
Lynn M. Schuchter, MD
Laurie H. Sehn, MD, MPH
Eric J. Sherman, MD
David S. Siegel, MD, PhD
Benjamin D. Smith, MD
Sonali Smith, MD
Lawrence J. Solin, MD
Neil L. Spector, MD
David P. Steensma, MD
T
William P. Tew, MD
Carol Tringali, MS, RN
Debu Tripathy, MD
Apostolia Tsimberidou, MD, PhD
Tim Turnham, PhD
Christopher Twelves, MD
V
Linda T. Vahdat, MD
Katherine Virgo, PhD
Rogerio Vivaldi, MD
Nicholas J. Vogelzang, MD
Everett E. Vokes, MD
W
Heather Wakelee, MD
H. Jack West, MD
Timothy J. Whelan, BM, BCh
Julia R. White, MD
Julia Whiteker, MSN, RN
Pat W. Whitworth, MD
William G. Wierda, MD, PhD
Jedd D. Wolchok, MD, PhD
Antonio C. Wolff, MD
Teresa K. Woodruff, PhD
Y
Ken Y. Yoneda, MD
Rex Chin-Wei Yung, MD
Z
Andrew D. Zelenetz, MD
External Resources
American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
OncLive Resources
Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives
About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747
Copyright HCPLive 2006-2012
Intellisphere, LLC. All Rights Reserved.
Email:
Password:
Become a Member
Forgot Password?